Literature DB >> 20460739

Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death.

Takashi Muraguchi1, Akiyuki Kawawa, Shunichiro Kubota.   

Abstract

We recently demonstrated that short time exposure to hypoxia (15 min) in H9c2 cardiomyocytes protected cells against cell death, and longer exposure to hypoxia induced cell death. To understand the molecular mechanism concerning cell death and survival, it is intriguing to identify survival factors against cell death. Using proteomics analysis, levels of proteins derived from H9c2 cells exposed to hypoxia and normoxia were compared and candidates for survival factor were identified. One of the candidates was a prohibitin. Overexpression of prohibitin inhibited H9c2 cell death induced by hypoxia for longer hours. We further clarified the mechanism of cell death. Overexpression of prohibitin inhibited decrease of mitochondrial membrane potential levels, decrease of Bcl-2 level in mitochondria and cytochrome c release to cytosol from mitochondria induced by hypoxia. The mechanism for survival was that overexpression of prohibitin inhibited cytochrome c release by decrease of mitochondrial membrane potential levels and decrease of Bcl-2 level. Taken together, identified prohibitin may function as a survival factor against hypoxiainduced cell death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460739     DOI: 10.2220/biomedres.31.113

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  18 in total

1.  Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.

Authors:  Debashis Dutta; Nilufar Ali; Emili Banerjee; Raghavendra Singh; Amit Naskar; Ramesh Kumar Paidi; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

Review 2.  The role and therapeutic potential of prohibitin in disease.

Authors:  Arianne L Theiss; Shanthi V Sitaraman
Journal:  Biochim Biophys Acta       Date:  2011-02-04

3.  Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities.

Authors:  Ping Zhou; Liping Qian; Marilena D'Aurelio; Sunghee Cho; Gang Wang; Giovanni Manfredi; Virginia Pickel; Costantino Iadecola
Journal:  J Neurosci       Date:  2012-01-11       Impact factor: 6.167

4.  Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier.

Authors:  Young-Wook Won; Arlo N McGinn; Minhyung Lee; David A Bull; Sung Wan Kim
Journal:  Mol Pharm       Date:  2012-12-18       Impact factor: 4.939

Review 5.  Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway.

Authors:  Indrajit Chowdhury; Winston E Thompson; Kelwyn Thomas
Journal:  J Cell Physiol       Date:  2014-08       Impact factor: 6.384

6.  COMP-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity.

Authors:  Yiting Jia; Meili Wang; Chenfeng Mao; Fang Yu; Yingbao Wang; Rui Xiao; Changtao Jiang; Lemin Zheng; Qingbo Xu; Ming Zheng; Yi Fu; Qinghua Hu; Wei Kong
Journal:  Cell Death Dis       Date:  2018-06-04       Impact factor: 8.469

7.  Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity.

Authors:  Asma Begum; Qun Lin; Chenye Yu; Yuri Kim; Zhong Yun
Journal:  Mol Cancer Res       Date:  2013-11-18       Impact factor: 5.852

8.  All-trans retinoic acid treatment is associated with prohibitin expression in renal interstitial fibrosis rats.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Zheng-Yi Li; Hui-Ling Xu; Yan-Jun Zhao; Feng-Ying Lei
Journal:  Int J Mol Sci       Date:  2012-03-01       Impact factor: 6.208

Review 9.  Multifaceted role of prohibitin in cell survival and apoptosis.

Authors:  Ya-Ting Peng; Ping Chen; Ruo-Yun Ouyang; Lei Song
Journal:  Apoptosis       Date:  2015-09       Impact factor: 4.677

10.  Less expression of prohibitin is associated with increased paired box 2 (PAX2) in renal interstitial fibrosis rats.

Authors:  Tian-Biao Zhou; Zhi-Yu Zeng; Yuan-Han Qin; Yan-Jun Zhao
Journal:  Int J Mol Sci       Date:  2012-08-06       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.